RetaMaps

Jaime Almandoz, M.D.

Jaime Almandoz, M.D. · 5323 HARRY HINES BLVD · Dallas, TX 75390

4.1· 14 Google reviews

Listing updated October 2, 2026

Retatrutide outlook for this practice

No current plans confirmed — RetaMaps has not yet confirmed this practice's intentions regarding retatrutide. Inclusion on RetaMaps does not mean the provider offers or will offer retatrutide.

Care described on the practice's website

  • Medically supervised weight loss
  • Endocrine / metabolic care

About this practice

Jaime Almandoz, M.D. is a physician in Dallas, Texas, listed for weight-loss care and endocrine care, with telehealth available. The website tied to the listing is UT Southwestern Medical Center's, which describes a network of more than 2,000 experts sharing one electronic record. Google reviews give a 4.1-star rating across 14 reviews dating back to 2017, with 1 in the past year; the staff is mentioned most, followed by scheduling, with two reviews each noting results and a caring manner.

Services & access

Advertises semaglutide todayNot listed
Advertises tirzepatide todayNot listed
Telehealth visitsYes
Cash pay acceptedYes
Accepts insurance — per practice websiteYes
Accepting new patients — per practice websiteYes

"Not listed" means we didn't find this stated on the practice's public pages — it doesn't mean no. — means unknown. Medication rows describe currently FDA-approved GLP-1 medications the practice advertises today, not retatrutide. Confirm details directly with the practice.

Review activity

★ 4.1
Google rating · 14 reviews
1
reviews in the past year (avg ★ 5.0)
2
reviews mention weight loss

Counts computed by RetaMaps from public Google reviews; most recent review 2026-04-04. Read the reviews themselves on the practice's Google listing.

What patients say

Rated ★4.1 across 14 Google reviews. Of the 14 reviews we analyzed, 11 (79%) are positive (4–5★) and 3 (21%) are negative (1–2★).

What patients like

  • Friendly, helpful staff6 reviews
  • Feeling listened to2 reviews
  • Easy scheduling and communication2 reviews

Common complaints

Very few complaints — only 3 negative reviews, with no recurring theme.

5★
11
4★
0
3★
0
2★
0
1★
3

Most recent Google reviews

Ar M.★★★★★2026-04-04

Hi 👋 We help businesses grow on YouTube, Instagram & Facebook with content + ads 🚀 Would you like a quick strategy for your brand? — Eaglix Media

Eboni C.★★★★★2025-03-14

I first called this office on February 25th, 2025 to see if I can be seen by Dr. Almandoz at the weight wellness clinic because I heard such good reviews about his work. I was told that I would need a referral. A couple of days later I sent over a referral, only to be told that it needs to be specifically for weight loss. A couple of days later, I had a new referral sent over specifically for weight loss. I followed up a few days later again, only to be told that my referral was denied because it needs to come from a PCP, in order for my insurance to cover it. I then had my PCP (a second doctor) to send over the referral. I again followed up a few days later to be told that the office has not received a referral yet. I informed them that I was able to see that the referral was sent over in MyChart. I was then put on hold and someone came back to say that they have put the referral in, and I will be contacted soon for an appointment. A few more days went by and I decided to follow up since I had not been contacted for an appointment and I was told that my referral was denied a 3rd time due to capacity management. I asked to speak with a supervisor because the information has been al

Mariam A.★★★★★2024-04-15

I called this office a couple of weeks back to see if Dr. Almandoz was accepting new patients, and was told (wish I had gotten her name, but sadly didn't) that he is, but requires a referral from the PCP. I went through the trouble of going through my PCP, etc to get this referral. When I haven't heard from this office after about a week after the referral was sent, I thought I'd call for update. It was then I was told that Dr. Almandoz is at capacity and was not accepting any new patients. I told this lady (different from the one I spoke to the first time I called the office) that I was told differently a mere two weeks ago. This lady said that she wasn't sure what that person said, but they have been at capacity since Nov/Dec. I was obviously annoyed and disappointed. But if the front office has such poor communication amongst each other, and are so unorganized, maybe it was for the best I didn't see this doctor.

Patsy R.★★★★★2023-07-24

I just really like the staff and Dr Almondoz along with his nutritionist. Everyone treated me with so much care.

Nancy A.★★★★★2023-05-15

Just spent 7.5 minutes listening to commercials - no one ever came to the phone.

Analysis by RetaMaps of reviews on this practice's public Google Business listing; review themes are detected automatically and reviews reflect their authors' opinions. See all reviews on Google.

Clinicians

  • Jaime Almandoz, M.D.

Nearby providers in Dallas

Retatrutide status
Phase 3 complete · Not FDA-approvedUpdated October 2, 2026

Retatrutide is Eli Lilly's investigational once-weekly triple agonist (GIP, GLP-1 and glucagon receptors). Five Phase 3 trials have reported positive results, and Lilly plans to submit it to the FDA in Q1 2027. It is not FDA-approved, has no brand name or price, and cannot be prescribed outside clinical trials or Lilly's physician-requested expanded access program. Products sold online as "research" or compounded retatrutide are not legitimate retatrutide.

Development
Phase 3 complete
FDA status
Submission planned — Q1 2027 (Lilly guidance)
Availability
Not commercially available
Access routes
Clinical trials, or Lilly's expanded access program (physician must apply)

Next milestone: TRIUMPH-5 head-to-head vs tirzepatide results (Expected ~Dec 2026)

Sources: Lilly — What to know about retatrutide · Lilly — TRIUMPH-2/TRIUMPH-3 results · BioPharma Dive — FDA submission plans · STAT — Lilly expanded access (Aug 3, 2026) · FDA — Concerns with unapproved GLP-1 drugs